Promoting equitable lung cancer screening for Hispanic current and former smokers
Official title: Health Opportunities and Promoters of Equitable Screening for Lung Cancer (HOPES for Lung Cancer)
Run by Massachusetts General Hospital · NCT05784922 · Data updated 2026-11-12
This project will try showing a short educational video to Hispanic current and former smokers to see if it increases interest in and uptake of lung cancer screening.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | February 3, 2023 |
| Main results expected | January 31, 2028 |
| Study ends | January 31, 2028 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT05784922 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Hispanic adults 50–80 years old who are current smokers or former smokers who quit within 15 years or have a history of ≥20 pack-years, speak English or Spanish, and are not currently enrolled in lung cancer screening.
✕Probably not a fit
People already enrolled in lung cancer screening, those with a current lung cancer diagnosis, individuals with cognitive inability to consent or complete surveys, or individuals outside the age or smoking-history criteria are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will recruit Hispanic adults aged 50–80 who are current or former smokers and not currently enrolled in lung cancer screening. Participants will view a culturally tailored educational video delivered digitally and then complete brief self-report surveys about smoking documentation, screening interest, and intent to schedule screening. The study will explore barriers to consistent identification and documentation of smoking status and measure feasibility, acceptability, and reach of the digital video delivery. Results will inform future interventions aimed at increasing lung cancer screening uptake in this underserved population.
Why it matters
Potential benefit: If successful, the approach could increase screening rates and earlier detection of lung cancer among Hispanic smokers, potentially improving survival in this group.
How similar studies have gone: Educational outreach has increased screening uptake in other populations, but few studies have tested digitally delivered, culturally tailored videos specifically for Hispanic current and former smokers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must be 50-80 years old * Are a current or former smoker (quit within 15 years, or a cumulative smoking status of \> 20 pack-years) * Not currently enrolled in Lung Cancer Screening * Must speak English or Spanish Exclusion Criteria: * Has a clinical cognitive inability to provide informed consent for participation in the study or complete a brief survey * Currently diagnosed with lung cancer * Currently enrolled in lung cancer screening * Have participated in the focus groups discussions from Aim 1
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Efren Flores, MD — Massachusetts General Hospital
- Study coordinator: Efren Flores, MD
- Email: ejflores@mgh.harvard.edu
- Phone: 617-724-4254
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI analysis of ECGs to detect structural heart disease
This project will test whether AI can read traditional and wearable ECGs to find undiagnosed valve disease, pulmonary hypertension, and heart failure in adults.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.